Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765838
Status:
RECRUITING
Last Update Posted:
2023-03-28
First Post:
2023-03-01
Brief Title:
Combined Molecular Testing for Influenza SARS-CoV-2 and RSV RNA From Different Upper Airway Specimens
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Study Overview
Official Title:
Combined Molecular Testing for Influenza SARS-CoV-2 and RSV RNA From Different Upper Airway Specimens
Status:
RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a comparative prospective diagnostic accuracy study reported according to the STARD guidelines Citizens at an outpatient COVID19 test facility at Testcenter Danmark Valby will be invited to participate in the study on a volunteer basis The enrolled participants will have the planned oropharyngeal swab performed in the test center and sent for a SARS-CoV-2 RT-PCR test at TestCenter Danmark Statens Serum Institut Copenhagen Denmark as usual Besides the planned oropharyngeal swab performed in the test center the participants will have additional specimens collected in form of saliva nasopharyngeal- nasal- and oropharyngeal swabs These will all be used for the detection of nucleic acids from the four most common strains of influenza B Yamagata B Victoria A H1N1 and A H3N2 SARS-CoV-2 and RSV AB Further we will measure immune mediating cytokines chemokines and interleukins in the different specimens These analyses will be performed at Technical University of Denmark DTU
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None